Related Experiment Video
Updated: Sep 24, 2026

Effects of Allogeneic Platelet-Rich Plasma (PRP) on the Healing Process of Sectioned Achilles Tendons of Rats: A Methodological Description
Published on: March 19, 2018
The effects of a minidose of heparin on peritonitis in rats
Abstract:
Sprague-Dawley rats with peritonitis treated with either a subcutaneous or intraperitoneal minidose of heparin show a significant increase in survival time when compared with controls. In the treatment groups, adhesions and abscesses were less severe and localized to the area of gangrenous bowel. Heparin also significantly reduced the incidence of recovery of viable bacteria from the blood and peritoneal cavity. These findings may be related to a decreased deposition of fibrinogen within the abdomen or to the early mobilization of fibrin.
Insights
Minidose heparin administration significantly improved survival rates in rats with peritonitis. This treatment reduced adhesions, abscesses, and bacterial recovery, suggesting a role in mitigating infection complications.
Area of Science:
- Peritonitis and infection research
- Pharmacological interventions in critical care
Background:
- Peritonitis is a serious abdominal infection often leading to complications like adhesions, abscesses, and sepsis.
- Current treatments focus on antibiotics and surgical intervention, but mortality remains significant.
Purpose of the Study:
- To investigate the efficacy of minidose heparin in improving survival and reducing complications in a rat model of peritonitis.
- To explore the potential mechanisms by which heparin might exert its effects in this context.
Main Methods:
- Sprague-Dawley rats were induced with peritonitis and treated with subcutaneous or intraperitoneal minidose heparin.
- Survival time, severity of adhesions and abscesses, and bacterial recovery from blood and peritoneal fluid were assessed.
- Control groups received no heparin treatment.
Main Results:
- Heparin treatment significantly increased survival time compared to controls.
- Adhesions and abscesses were less severe and localized in heparin-treated rats.
- A significant reduction in the recovery of viable bacteria from blood and peritoneal cavities was observed in the treatment groups.
Conclusions:
- Minidose heparin demonstrates a protective effect in experimental peritonitis, enhancing survival and reducing infectious complications.
- The observed benefits may stem from reduced fibrinogen deposition or enhanced fibrinolysis within the abdominal cavity.
- Heparin represents a potential adjunctive therapy for peritonitis, warranting further investigation.

